{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/hhs/rules/recent","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.federalregister.gov/agencies/health-and-human-services-department","generated_at":"2026-10-24T18:50:32.271Z"},"count":50,"items":[{"document_number":"2026-20979","title":"Food Additives Permitted in Feed and Drinking Water of Animals; Chromium Propionate","publication_date":"2026-10-14","effective_date":"2026-10-14","category":"fda-food","sub_agency":"FDA","cfr_part":"21 CFR 573","citation":"91 FR 65109","html_url":"https://www.federalregister.gov/documents/2026/10/14/2026-20979/food-additives-permitted-in-feed-and-drinking-water-of-animals-chromium-propionate","canonical_url":"https://api.morvs.ai/hhs-rule/2026-20979"},{"document_number":"2026-20848","title":"Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods","publication_date":"2026-10-13","effective_date":"2026-12-14","category":"other","sub_agency":"FDA","cfr_part":"21 CFR 130","citation":"91 FR 65040","html_url":"https://www.federalregister.gov/documents/2026/10/13/2026-20848/use-of-salt-substitutes-to-reduce-the-sodium-content-in-standardized-foods","canonical_url":"https://api.morvs.ai/hhs-rule/2026-20848"},{"document_number":"2026-20727","title":"Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections Using Home-Collected Specimens","publication_date":"2026-10-09","effective_date":"2026-10-09","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 866","citation":"91 FR 64611","html_url":"https://www.federalregister.gov/documents/2026/10/09/2026-20727/medical-devices-immunology-and-microbiology-devices-classification-of-the-system-for-detection-of","canonical_url":"https://api.morvs.ai/hhs-rule/2026-20727"},{"document_number":"2026-20726","title":"Medical Devices; Cardiovascular Devices; Classification of the Infant Pulse Rate and Oxygen Saturation Monitor for Over-the-Counter Use","publication_date":"2026-10-09","effective_date":"2026-10-09","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 870","citation":"91 FR 64615","html_url":"https://www.federalregister.gov/documents/2026/10/09/2026-20726/medical-devices-cardiovascular-devices-classification-of-the-infant-pulse-rate-and-oxygen-saturation","canonical_url":"https://api.morvs.ai/hhs-rule/2026-20726"},{"document_number":"2026-20725","title":"Medical Devices; Immunology and Microbiology Devices; Classification of the Hematopoietic Cell Enrichment Kit","publication_date":"2026-10-09","effective_date":"2026-10-09","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 866","citation":"91 FR 64609","html_url":"https://www.federalregister.gov/documents/2026/10/09/2026-20725/medical-devices-immunology-and-microbiology-devices-classification-of-the-hematopoietic-cell","canonical_url":"https://api.morvs.ai/hhs-rule/2026-20725"},{"document_number":"2026-20685","title":"Removal of Obsolete Portion of Regulation Relating to Care and Treatment of Ineligible Individuals","publication_date":"2026-10-08","effective_date":"2026-12-07","category":"tribal-health","sub_agency":"IHS","cfr_part":"42 CFR 136","citation":"91 FR 64301","html_url":"https://www.federalregister.gov/documents/2026/10/08/2026-20685/removal-of-obsolete-portion-of-regulation-relating-to-care-and-treatment-of-ineligible-individuals","canonical_url":"https://api.morvs.ai/hhs-rule/2026-20685"},{"document_number":"2026-20684","title":"Removal of Obsolete/Suspended Regulations","publication_date":"2026-10-08","effective_date":"2026-12-07","category":"tribal-health","sub_agency":"IHS","cfr_part":"42 CFR 136","citation":"91 FR 64302","html_url":"https://www.federalregister.gov/documents/2026/10/08/2026-20684/removal-of-obsoletesuspended-regulations","canonical_url":"https://api.morvs.ai/hhs-rule/2026-20684"},{"document_number":"2026-20448","title":"Medical Devices; Exemptions From Premarket Notification: Class II Devices; Certain Clinical Toxicology Test Systems","publication_date":"2026-10-06","effective_date":"2026-10-06","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 862","citation":"91 FR 63478","html_url":"https://www.federalregister.gov/documents/2026/10/06/2026-20448/medical-devices-exemptions-from-premarket-notification-class-ii-devices-certain-clinical-toxicology","canonical_url":"https://api.morvs.ai/hhs-rule/2026-20448"},{"document_number":"2026-20447","title":"Transparency in Coverage","publication_date":"2026-10-06","effective_date":"2026-12-07","category":"other","sub_agency":"HHS","cfr_part":"26 CFR 54","citation":"91 FR 63748","html_url":"https://www.federalregister.gov/documents/2026/10/06/2026-20447/transparency-in-coverage","canonical_url":"https://api.morvs.ai/hhs-rule/2026-20447"},{"document_number":"2026-20443","title":"Medical Devices; Immunology and Microbiology Devices; Classification of the High Throughput DNA Sequencing for Hereditary Cancer Predisposition Assessment Test System","publication_date":"2026-10-06","effective_date":"2026-10-06","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 866","citation":"91 FR 63487","html_url":"https://www.federalregister.gov/documents/2026/10/06/2026-20443/medical-devices-immunology-and-microbiology-devices-classification-of-the-high-throughput-dna","canonical_url":"https://api.morvs.ai/hhs-rule/2026-20443"},{"document_number":"2026-20441","title":"Medical Devices; Cardiovascular Devices; Classification of the Hyperoxia Monitoring Device Adjunct to Pulse Oximetry","publication_date":"2026-10-06","effective_date":"2026-10-06","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 870","citation":"91 FR 63491","html_url":"https://www.federalregister.gov/documents/2026/10/06/2026-20441/medical-devices-cardiovascular-devices-classification-of-the-hyperoxia-monitoring-device-adjunct-to","canonical_url":"https://api.morvs.ai/hhs-rule/2026-20441"},{"document_number":"2026-20440","title":"Medical Devices; General and Plastic Surgery Devices; Classification of the Focused Ultrasound System for Non-Thermal, Mechanical Tissue Ablation","publication_date":"2026-10-06","effective_date":"2026-10-06","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 878","citation":"91 FR 63493","html_url":"https://www.federalregister.gov/documents/2026/10/06/2026-20440/medical-devices-general-and-plastic-surgery-devices-classification-of-the-focused-ultrasound-system","canonical_url":"https://api.morvs.ai/hhs-rule/2026-20440"},{"document_number":"2026-20281","title":"Global Benchmark for Efficient Drug Pricing (GLOBE) Model","publication_date":"2026-10-02","effective_date":"2026-11-30","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 513","citation":"91 FR 62936","html_url":"https://www.federalregister.gov/documents/2026/10/02/2026-20281/global-benchmark-for-efficient-drug-pricing-globe-model","canonical_url":"https://api.morvs.ai/hhs-rule/2026-20281"},{"document_number":"2026-20134","title":"Medicare Program; FY 2027 Inpatient Psychiatric Facilities Prospective Payment System-Rate Update; Correction","publication_date":"2026-10-01","effective_date":"2026-10-01","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 412","citation":"91 FR 62323","html_url":"https://www.federalregister.gov/documents/2026/10/01/2026-20134/medicare-program-fy-2027-inpatient-psychiatric-facilities-prospective-payment-system-rate-update","canonical_url":"https://api.morvs.ai/hhs-rule/2026-20134"},{"document_number":"2026-20131","title":"Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2027 and Updates to the IRF Quality Reporting Program; Correction","publication_date":"2026-10-01","effective_date":"2026-10-01","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 412","citation":"91 FR 62327","html_url":"https://www.federalregister.gov/documents/2026/10/01/2026-20131/medicare-program-inpatient-rehabilitation-facility-prospective-payment-system-for-federal-fiscal","canonical_url":"https://api.morvs.ai/hhs-rule/2026-20131"},{"document_number":"2026-20075","title":"Medical Devices; Gastroenterology-Urology Devices; Classification of the Flushing and Storage Solution for Vascular Autografts at Room Temperature","publication_date":"2026-09-30","effective_date":"2026-09-30","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 876","citation":"91 FR 61703","html_url":"https://www.federalregister.gov/documents/2026/09/30/2026-20075/medical-devices-gastroenterology-urology-devices-classification-of-the-flushing-and-storage-solution","canonical_url":"https://api.morvs.ai/hhs-rule/2026-20075"},{"document_number":"2026-20067","title":"Medicare Program; FY 2027 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Program Requirements; Correction","publication_date":"2026-09-30","effective_date":"2026-10-01","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 418","citation":"91 FR 61791","html_url":"https://www.federalregister.gov/documents/2026/09/30/2026-20067/medicare-program-fy-2027-hospice-wage-index-and-payment-rate-update-and-hospice-quality-reporting","canonical_url":"https://api.morvs.ai/hhs-rule/2026-20067"},{"document_number":"2026-19959","title":"Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program for Federal Fiscal Year 2027; Correction","publication_date":"2026-09-30","effective_date":"2026-10-01","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 413","citation":"91 FR 61782","html_url":"https://www.federalregister.gov/documents/2026/09/30/2026-19959/medicare-program-prospective-payment-system-and-consolidated-billing-for-skilled-nursing-facilities","canonical_url":"https://api.morvs.ai/hhs-rule/2026-19959"},{"document_number":"2026-19946","title":"Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals (IPPS) and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year (FY) 2027 Rates; Requirements for Quality Programs; Other Policy Changes; and Adoption of Updated Versions of Certain Health Information Technology Standards; Correction","publication_date":"2026-09-29","effective_date":"2026-10-01","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 405","citation":"91 FR 61328","html_url":"https://www.federalregister.gov/documents/2026/09/29/2026-19946/medicare-program-hospital-inpatient-prospective-payment-systems-for-acute-care-hospitals-ipps-and","canonical_url":"https://api.morvs.ai/hhs-rule/2026-19946"},{"document_number":"2026-19656","title":"Food Additives Permitted for Direct Addition to Food for Human Consumption; Vitamin D2 Inactive Bakers Yeast","publication_date":"2026-09-25","effective_date":"2026-09-25","category":"fda-food","sub_agency":"FDA","cfr_part":"21 CFR 172","citation":"91 FR 60796","html_url":"https://www.federalregister.gov/documents/2026/09/25/2026-19656/food-additives-permitted-for-direct-addition-to-food-for-human-consumption-vitamin-d2-inactive","canonical_url":"https://api.morvs.ai/hhs-rule/2026-19656"},{"document_number":"2026-19493","title":"Patient Protection and Affordable Care Act; Temporary Moratoria on Certain Agent and Broker Registration To Participate in the Exchanges","publication_date":"2026-09-23","effective_date":"2026-09-22","category":"medicare","sub_agency":"CMS","cfr_part":"45 CFR 155","citation":"91 FR 60317","html_url":"https://www.federalregister.gov/documents/2026/09/23/2026-19493/patient-protection-and-affordable-care-act-temporary-moratoria-on-certain-agent-and-broker","canonical_url":"https://api.morvs.ai/hhs-rule/2026-19493"},{"document_number":"2026-19350","title":"Nonclinical Testing Terminology","publication_date":"2026-09-22","effective_date":"2027-02-04","category":"other","sub_agency":"FDA","cfr_part":"21 CFR 312","citation":"91 FR 59988","html_url":"https://www.federalregister.gov/documents/2026/09/22/2026-19350/nonclinical-testing-terminology","canonical_url":"https://api.morvs.ai/hhs-rule/2026-19350"},{"document_number":"2026-19074","title":"Medical Devices; Exemption From Premarket Notification: Radiology Computer-Aided Detection and/or Diagnosis Devices and Computer-Aided Triage and Notification Devices","publication_date":"2026-09-17","effective_date":"2026-09-17","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 892","citation":"91 FR 58817","html_url":"https://www.federalregister.gov/documents/2026/09/17/2026-19074/medical-devices-exemption-from-premarket-notification-radiology-computer-aided-detection-andor","canonical_url":"https://api.morvs.ai/hhs-rule/2026-19074"},{"document_number":"2026-18612","title":"Medical Devices; Cardiovascular Devices; Classification of the Cardiovascular Machine Learning-Based Notification Software","publication_date":"2026-09-11","effective_date":"2026-09-11","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 870","citation":"91 FR 57785","html_url":"https://www.federalregister.gov/documents/2026/09/11/2026-18612/medical-devices-cardiovascular-devices-classification-of-the-cardiovascular-machine-learning-based","canonical_url":"https://api.morvs.ai/hhs-rule/2026-18612"},{"document_number":"2026-18433","title":"Medical Devices; Cardiovascular Devices; Classification of the Mechanical Deviation Device for Esophageal Protection During Cardiac Ablation Procedures","publication_date":"2026-09-10","effective_date":"2026-09-10","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 870","citation":"91 FR 57495","html_url":"https://www.federalregister.gov/documents/2026/09/10/2026-18433/medical-devices-cardiovascular-devices-classification-of-the-mechanical-deviation-device-for","canonical_url":"https://api.morvs.ai/hhs-rule/2026-18433"},{"document_number":"2026-18432","title":"Medical Devices; Cardiovascular Devices; Classification of the Temperature Regulation Device for Esophageal Protection During Cardiac Ablation Procedures","publication_date":"2026-09-10","effective_date":"2026-09-10","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 870","citation":"91 FR 57500","html_url":"https://www.federalregister.gov/documents/2026/09/10/2026-18432/medical-devices-cardiovascular-devices-classification-of-the-temperature-regulation-device-for","canonical_url":"https://api.morvs.ai/hhs-rule/2026-18432"},{"document_number":"2026-18431","title":"Medical Devices; Cardiovascular Devices; Classification of the Extravascular Support for an Arteriovenous Fistula for Vascular Access","publication_date":"2026-09-10","effective_date":"2026-09-10","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 870","citation":"91 FR 57498","html_url":"https://www.federalregister.gov/documents/2026/09/10/2026-18431/medical-devices-cardiovascular-devices-classification-of-the-extravascular-support-for-an","canonical_url":"https://api.morvs.ai/hhs-rule/2026-18431"},{"document_number":"2026-18430","title":"Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Anti-Tumor Necrosis Factor Alpha Monoclonal Antibody Test System for Inflammatory Bowel Disease","publication_date":"2026-09-10","effective_date":"2026-09-10","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 862","citation":"91 FR 57493","html_url":"https://www.federalregister.gov/documents/2026/09/10/2026-18430/medical-devices-clinical-chemistry-and-clinical-toxicology-devices-classification-of-the-anti-tumor","canonical_url":"https://api.morvs.ai/hhs-rule/2026-18430"},{"document_number":"2026-18429","title":"Medical Devices; Ear, Nose, and Throat Devices; Classification of the Cooperative Powered Surgical Assist Device for ENT Surgery","publication_date":"2026-09-10","effective_date":"2026-09-10","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 874","citation":"91 FR 57502","html_url":"https://www.federalregister.gov/documents/2026/09/10/2026-18429/medical-devices-ear-nose-and-throat-devices-classification-of-the-cooperative-powered-surgical","canonical_url":"https://api.morvs.ai/hhs-rule/2026-18429"},{"document_number":"2026-18428","title":"Medical Devices; Gastroenterology-Urology Devices; Classification of the Implanted Tibial Electrical Urinary Continence Device","publication_date":"2026-09-10","effective_date":"2026-09-10","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 876","citation":"91 FR 57504","html_url":"https://www.federalregister.gov/documents/2026/09/10/2026-18428/medical-devices-gastroenterology-urology-devices-classification-of-the-implanted-tibial-electrical","canonical_url":"https://api.morvs.ai/hhs-rule/2026-18428"},{"document_number":"2026-18427","title":"Medical Devices; Radiology Devices; Classification of the Vaginal Hydrogel Packing System","publication_date":"2026-09-10","effective_date":"2026-09-10","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 892","citation":"91 FR 57509","html_url":"https://www.federalregister.gov/documents/2026/09/10/2026-18427/medical-devices-radiology-devices-classification-of-the-vaginal-hydrogel-packing-system","canonical_url":"https://api.morvs.ai/hhs-rule/2026-18427"},{"document_number":"2026-18426","title":"Medical Devices; General Hospital and Personal Use Devices; Classification of the Whole Room Microbial Reduction Device","publication_date":"2026-09-10","effective_date":"2026-09-10","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 880","citation":"91 FR 57507","html_url":"https://www.federalregister.gov/documents/2026/09/10/2026-18426/medical-devices-general-hospital-and-personal-use-devices-classification-of-the-whole-room-microbial","canonical_url":"https://api.morvs.ai/hhs-rule/2026-18426"},{"document_number":"2026-17622","title":"Federal Independent Dispute Resolution Operations; Correction","publication_date":"2026-08-28","effective_date":"2026-08-28","category":"other","sub_agency":"HHS","cfr_part":"26 CFR 54","citation":"91 FR 55462","html_url":"https://www.federalregister.gov/documents/2026/08/28/2026-17622/federal-independent-dispute-resolution-operations-correction","canonical_url":"https://api.morvs.ai/hhs-rule/2026-17622"},{"document_number":"2026-16942","title":"Food Additives Permitted in Feed and Drinking Water of Animals; Chromium DL-methionine Chelate","publication_date":"2026-08-19","effective_date":"2026-08-19","category":"fda-food","sub_agency":"FDA","cfr_part":"21 CFR 573","citation":"91 FR 53524","html_url":"https://www.federalregister.gov/documents/2026/08/19/2026-16942/food-additives-permitted-in-feed-and-drinking-water-of-animals-chromium-dl-methionine-chelate","canonical_url":"https://api.morvs.ai/hhs-rule/2026-16942"},{"document_number":"2026-16727","title":"Hematology and Pathology Devices; Reclassification of In Situ Hybridization Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product","publication_date":"2026-08-17","effective_date":"2026-09-16","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 864","citation":"91 FR 53184","html_url":"https://www.federalregister.gov/documents/2026/08/17/2026-16727/hematology-and-pathology-devices-reclassification-of-in-situ-hybridization-test-systems-for-use-with","canonical_url":"https://api.morvs.ai/hhs-rule/2026-16727"},{"document_number":"2026-16508","title":"Medicaid Program; Prohibition on Federal Medicaid and Children's Health Insurance Program Funding for Sex-Rejecting Procedures Furnished to Children","publication_date":"2026-08-13","effective_date":"2026-10-13","category":"medicaid","sub_agency":"CMS","cfr_part":"42 CFR 441","citation":"91 FR 52406","html_url":"https://www.federalregister.gov/documents/2026/08/13/2026-16508/medicaid-program-prohibition-on-federal-medicaid-and-childrens-health-insurance-program-funding-for","canonical_url":"https://api.morvs.ai/hhs-rule/2026-16508"},{"document_number":"2026-16420","title":"Guide To Minimize Biological Hazards in Ready-to-Eat Fresh-Cut Produce; Guidance for Industry; Availability","publication_date":"2026-08-12","effective_date":null,"category":"other","sub_agency":"FDA","cfr_part":"21 CFR 117","citation":"91 FR 52011","html_url":"https://www.federalregister.gov/documents/2026/08/12/2026-16420/guide-to-minimize-biological-hazards-in-ready-to-eat-fresh-cut-produce-guidance-for-industry","canonical_url":"https://api.morvs.ai/hhs-rule/2026-16420"},{"document_number":"2026-15963","title":"Medical Devices; Radiology Devices; Classification of the Fludeoxyglucose F18-Guided Radiation Therapy System","publication_date":"2026-08-06","effective_date":"2026-08-06","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 892","citation":"91 FR 50708","html_url":"https://www.federalregister.gov/documents/2026/08/06/2026-15963/medical-devices-radiology-devices-classification-of-the-fludeoxyglucose-f18-guided-radiation-therapy","canonical_url":"https://api.morvs.ai/hhs-rule/2026-15963"},{"document_number":"2026-15920","title":"Micro-Tracers, Inc.; Response to Objections and Requests for a Public Hearing","publication_date":"2026-08-05","effective_date":"2027-01-15","category":"fda-food","sub_agency":"FDA","cfr_part":"21 CFR 74","citation":"91 FR 50475","html_url":"https://www.federalregister.gov/documents/2026/08/05/2026-15920/micro-tracers-inc-response-to-objections-and-requests-for-a-public-hearing","canonical_url":"https://api.morvs.ai/hhs-rule/2026-15920"},{"document_number":"2026-15833","title":"Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals (IPPS) and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year (FY) 2027 Rates; Requirements for Quality Programs; Other Policy Changes; and Adoption of Updated Versions of Certain Health Information Technology Standards","publication_date":"2026-08-04","effective_date":"2026-10-01","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 405","citation":"91 FR 49570","html_url":"https://www.federalregister.gov/documents/2026/08/04/2026-15833/medicare-program-hospital-inpatient-prospective-payment-systems-for-acute-care-hospitals-ipps-and","canonical_url":"https://api.morvs.ai/hhs-rule/2026-15833"},{"document_number":"2026-15686","title":"Medicare Program; FY 2027 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Program Requirements","publication_date":"2026-08-03","effective_date":"2026-10-01","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 418","citation":"91 FR 49118","html_url":"https://www.federalregister.gov/documents/2026/08/03/2026-15686/medicare-program-fy-2027-hospice-wage-index-and-payment-rate-update-and-hospice-quality-reporting","canonical_url":"https://api.morvs.ai/hhs-rule/2026-15686"},{"document_number":"2026-15681","title":"Reducing Bureaucracy and Burden in Family Violence and Prevention Services","publication_date":"2026-08-03","effective_date":"2026-10-02","category":"other","sub_agency":"HHS","cfr_part":"45 CFR 1370","citation":"91 FR 48775","html_url":"https://www.federalregister.gov/documents/2026/08/03/2026-15681/reducing-bureaucracy-and-burden-in-family-violence-and-prevention-services","canonical_url":"https://api.morvs.ai/hhs-rule/2026-15681"},{"document_number":"2026-15652","title":"Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2027 and Updates to the IRF Quality Reporting Program","publication_date":"2026-08-03","effective_date":"2026-10-01","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 412","citation":"91 FR 48982","html_url":"https://www.federalregister.gov/documents/2026/08/03/2026-15652/medicare-program-inpatient-rehabilitation-facility-prospective-payment-system-for-federal-fiscal","canonical_url":"https://api.morvs.ai/hhs-rule/2026-15652"},{"document_number":"2026-15588","title":"Medicare Program; FY 2027 Inpatient Psychiatric Facilities Prospective Payment System-Rate Update","publication_date":"2026-07-31","effective_date":"2026-10-01","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 412","citation":"91 FR 48514","html_url":"https://www.federalregister.gov/documents/2026/07/31/2026-15588/medicare-program-fy-2027-inpatient-psychiatric-facilities-prospective-payment-system-rate-update","canonical_url":"https://api.morvs.ai/hhs-rule/2026-15588"},{"document_number":"2026-15567","title":"Reducing Bureaucracy and Burden for Family Assistance Programs","publication_date":"2026-07-31","effective_date":"2026-09-29","category":"tribal-health","sub_agency":"IHS","cfr_part":"45 CFR 201","citation":"91 FR 48268","html_url":"https://www.federalregister.gov/documents/2026/07/31/2026-15567/reducing-bureaucracy-and-burden-for-family-assistance-programs","canonical_url":"https://api.morvs.ai/hhs-rule/2026-15567"},{"document_number":"2026-15562","title":"Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program for Federal Fiscal Year 2027","publication_date":"2026-07-31","effective_date":"2026-10-01","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 413","citation":"91 FR 48588","html_url":"https://www.federalregister.gov/documents/2026/07/31/2026-15562/medicare-program-prospective-payment-system-and-consolidated-billing-for-skilled-nursing-facilities","canonical_url":"https://api.morvs.ai/hhs-rule/2026-15562"},{"document_number":"2026-15446","title":"Medicare Program; Updates to the Master List of Items Potentially Subject to Face-to-Face Encounter and Written Order Prior to Delivery and/or Prior Authorization Requirements; Updates to the Required Face-to-Face Encounter and Written Order Prior to Delivery List; and Updates to the Required Prior Authorization List","publication_date":"2026-07-30","effective_date":"2026-10-28","category":"medicare","sub_agency":"CMS","cfr_part":"42 CFR 410","citation":"91 FR 47972","html_url":"https://www.federalregister.gov/documents/2026/07/30/2026-15446/medicare-program-updates-to-the-master-list-of-items-potentially-subject-to-face-to-face-encounter","canonical_url":"https://api.morvs.ai/hhs-rule/2026-15446"},{"document_number":"2026-15303","title":"Medical Devices; Radiology Devices; Classification of the Phase-Changing Fiducial Marker for Radiation Therapy","publication_date":"2026-07-29","effective_date":"2026-07-29","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 892","citation":"91 FR 47788","html_url":"https://www.federalregister.gov/documents/2026/07/29/2026-15303/medical-devices-radiology-devices-classification-of-the-phase-changing-fiducial-marker-for-radiation","canonical_url":"https://api.morvs.ai/hhs-rule/2026-15303"},{"document_number":"2026-15075","title":"Medical Devices; General Hospital and Personal Use Devices; Classification of the Active Noise Attenuation System for Infant Incubators","publication_date":"2026-07-27","effective_date":"2026-07-27","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 880","citation":"91 FR 46835","html_url":"https://www.federalregister.gov/documents/2026/07/27/2026-15075/medical-devices-general-hospital-and-personal-use-devices-classification-of-the-active-noise","canonical_url":"https://api.morvs.ai/hhs-rule/2026-15075"},{"document_number":"2026-15074","title":"Medical Devices; Gastroenterology-Urology Devices; Classification of the Non-Medicated Topical Formulation for Treatment of Erectile Dysfunction","publication_date":"2026-07-27","effective_date":"2026-07-27","category":"fda-device","sub_agency":"FDA","cfr_part":"21 CFR 876","citation":"91 FR 46833","html_url":"https://www.federalregister.gov/documents/2026/07/27/2026-15074/medical-devices-gastroenterology-urology-devices-classification-of-the-non-medicated-topical","canonical_url":"https://api.morvs.ai/hhs-rule/2026-15074"}]}